Antigen/Gene or Protein Targets: Oncofetal fibronectin extra domain-B (FN-EDB) and tenascin-C C domain (TNC-C). Relevant disease: Cancer
0
reviews
1
reference
1
supplier
PL3 Peptide
RECENTLY UPDATED
RECENTLY UPDATED
Invented by Prakash Lingasamy , Tambet Teesalu
Invented at University of Tartu
- Datasheet
- References (0)
- Inventor Info
Info
Catalogue Number | 157666 |
Amino Acid Sequence | AGRGRLVR |
Cellular/Tissue Localisation | PL3 is specific to tenascin-C C domain (TNC-C) |
Synonyms | PL3, Tenascin-C C domain specific peptide |
Relevance | Tenascin-C C domain (TNC-C) is not present in the extracellular matrix of adult tissues but it is up-regulated in tumours and malignant tissues. It has previously been used as a target for antibody-based therapies. PL3 is a specific peptide which has enhanced affinity to bind to TNC-C so PL3 may be useful as an affinity ligand for delivery of diagnostic compound into solid tumours. |
Antigen/Gene or Protein Targets | Tenascin-C C domain (TNC-C) |
Research Area | Cancer, Extracellular Matrix |
References
There are 0 reference entries for this reagent.
References: 0 entry
There is no reference for this reagent yet, feel free to use the button below to suggest one.
Add a reference
References: 0 entry
There is no reference for this reagent yet, feel free to use the button below to suggest one.
Add a reference
Inventor Information
Inventors
![]() |
Prakash Lingasamy |
![]() |
Tambet Teesalu |